| Stereochemistry | RACEMIC |
| Molecular Formula | C10H11NO3 |
| Molecular Weight | 193.1992 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(N)C(=O)C1=CC2=C(OCO2)C=C1
InChI
InChIKey=XDEZOLVDJWWXRG-UHFFFAOYSA-N
InChI=1S/C10H11NO3/c1-6(11)10(12)7-2-3-8-9(4-7)14-5-13-8/h2-4,6H,5,11H2,1H3
| Molecular Formula | C10H11NO3 |
| Molecular Weight | 193.1992 |
| Charge | 0 |
| Count |
MOL RATIO
1 MOL RATIO (average) |
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
BK-MDA (also known as3,4-methylenedioxycathinone or normethylone), a centrally active metabolite that contributes to overall effects of the drug methylone in vivo. Methylone is a new psychoactive substance that possesses anti-depressant and anti-Parkinson properties and is a frequently abused synthetic cathinone derivative.
